文献速递传染病防控与疫情报告免疫规划

噬菌体Sal-P001联合RAST002疫苗对沙门菌感染提供完全保护

Combination of lytic phage Sal-P001 and RAST002 vaccine induces complete protection against homologous and heterologous Salmonella strains.
PubMed 文献 · Vaccine · 2026-03-10

本研究分离裂解性噬菌体Sal-P001,鉴定为肌尾噬菌体,测定了其感染复数、潜伏期、爆发期和爆发量,并评估其与减毒活疫苗RAST002联合使用。联合给药诱导了较强的全身和黏膜免疫应答,小鼠在同源和异源沙门菌攻毒后存活率达100%。

要点

  • 噬菌体Sal-P001为肌尾噬菌体,最适感染复数为0.1,潜伏期20分钟,爆发期20-100分钟,爆发量458 PFU/细胞。
  • Sal-P001在37-72°C和pH 2-12范围内保持稳定。
  • Sal-P001联合RAST002疫苗诱导全身和黏膜免疫应答,小鼠多血清型沙门菌攻毒后存活率100%。

核心结论

  • 噬菌体Sal-P001与减毒活疫苗RAST002联合使用可诱导全身和黏膜免疫应答,并使小鼠在同源和异源沙门菌攻毒后获得100%存活。

研究设计与样本

  • 从家禽养殖场废水分离裂解性噬菌体Sal-P001,经透射电镜鉴定为肌尾噬菌体。
  • 测定Sal-P001的最适感染复数、潜伏期、爆发期、爆发量及温度(37-72°C)和pH(2-12)稳定性。
  • 评估Sal-P001与已开发的减毒活疫苗RAST002联合给药后的免疫应答及小鼠多血清型沙门菌攻毒保护效果。

主要发现

  • Sal-P001最适感染复数为0.1,潜伏期20分钟,爆发期20-100分钟,爆发量458 PFU/细胞。
  • Sal-P001在37-72°C和pH 2-12范围内保持稳定。
  • 联合给药诱导较强的全身和黏膜免疫应答。
  • 联合处理小鼠在多种沙门菌血清型攻毒后存活率达100%。

临床怎么用

  • 提示噬菌体与疫苗联合应用可能作为增强沙门菌感染保护的一种策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nontyphoidal Salmonella infections remain a major global health concern and were exacerbated by increasing antimicrobial resistance. In this study, a lytic bacteriophage, SalP001, was isolated from wastewater collected at a poultry farm. Transmission electron microscopy identified Sal-P001 as a myovirus. The phage exhibited an optimal multiplicity of infection of 0.1, a latent period of 20 min, a burst period of 20-100 min, and a burst size of 458 PFU/cell. Sal-P001 remained stable over a broad temperature (37-72 °C) and pH (2-12) range. We further evaluated the combined use of Sal-P001 with RAST002, a previously developed live attenuated Salmonella vaccine. Combined administration induced robust systemic and mucosal immune responses. Notably, mice receiving the combined treatment achieved 100% survival following challenge with multiple Salmonella serotypes. These findings highlight the potential of integrating bacteriophage application with vaccination as an effective strategy to enhance protection against Salmonella infections.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zhang J, Zhang Z, Yang D, et al. Combination of lytic phage Sal-P001 and RAST002 vaccine induces complete protection against homologous and heterologous Salmonella strains. Vaccine. 2026. PMID: 41812632. doi:10.1016/j.vaccine.2026.128451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。